Pharmacy Benefits Management Services Home

PDE5 inhibitors increase cGMPP levels and early therapy can reverse or minimise the effects of CVOD (5). Animal studies have shown that daily administration of a PDE5 inhibitor can prevent CVOD from developing and can normalise the abnormal corporal smooth muscle to collagen ratio that is seen following nerve resection (2). ................
................